why choose us

First received: December 12, 2022

Clinical Trial: Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Study Status: Completed

Recruit Status: RECRUITING

Condition: Autosomal Dominant Hypocalcemia (ADH)

Study Type: INTERVENTIONAL


Official Title: CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Brief Summary: The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with ADH1.

Read more